FDA
approval
· 2018-08-30
FDA Approved: DELSTRIGO — Original Application (Merck Sharp & Dohme LLC)
Summary
The FDA approved Delstrigo, a fixed-dose combination tablet containing doravirine, lamivudine, and tenofovir disoproxil fumarate, as a complete regimen for trea…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DELSTRIGO (DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE)